ASTRAZENECA PHARMA INDIA
Back to Cashflow Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹31 Cr | ₹5.23 Cr | ₹52 Cr | ₹96 Cr | ₹269 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹5.23 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹96 Cr |
| Mar2021 | ₹269 Cr |
How is Net Cash Inflow / Outflow of ASTRAZENECA PHARMA INDIA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 484.51 | |
| Mar2024 | ₹5.23 Cr | -89.93 | |
| Mar2023 | ₹52 Cr | -45.96 | |
| Mar2022 | ₹96 Cr | -64.26 | |
| Mar2021 | ₹269 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹20,135.4 Cr | -5.9% | -7% | -5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -5.9% |
-7% |
-5.6% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses